Publikationen von Kati Turkowski

Merkt, W.; Rodon, L.; Deicher, F. S.; Freitag, M.; Claus, M.; Lister, R.; Han, H.; Zhou, Y.; Horne, A.; Stutz, A. et al.; Li, Y.-N.; Kreuter, M.; Kahn, N.; Schneider, M. A.; Egea-Zorrilla, A.; Blasco-Iturri, Z.; Nikulina, N.; Turkowski, K.; Ruppert, C.; Guenther, A.; Rizzo, R.; Rizzo, S.; Ferraresi, M.; Hubschmann, D.; Haas, S.; Blank, N.; Watzl, C.; Tykocinski, L.-O.; Lorenz, H.-M.; Savai, R.; Pardo-Saganta, A.; Lagares, D.: Natural killer cell immunotherapy reverses lung fibrosis by eliminating senescent fibroblasts. SCIENCE TRANSLATIONAL MEDICINE 18 (849), eadq5442 (2026)

Dizdarevic, S.; Wiegandt, R.; Weigert, A.; Stiewe, T.; Eul, B.; Guenther, S.; Grimminger, F.; Seeger, W.; Pullamsetti, S. S.; Looso, M. et al.; Turkowski, K.; Savai, R.: Divergent CD45+ immune landscapes shape the lung tumor microenvironment. FRONTIERS IN IMMUNOLOGY 17, 1765833 (2026)

Neogi, U.; Ambikan, A. T.; Turkowski, K.; Schneider, M. A.; Beutgen, V. M.; Graumann, J.; Winter, H.; Bartkuhn, M.; Seeger, W.; Pullamsetti, S. S. et al.; Savai, R.: Plasma proteomic profiling and molecular clustering reveal immune-defined prognostic subtypes in lung adenocarcinoma. INTERNATIONAL JOURNAL OF CANCER (2025)

Turkowski, K.; Herzberg, F.; Guenther, S.; Weigert, A.; Haselbauer, T.; Fink, L.; Brunn, D.; Grimminger, F.; Seeger, W.; Sueltmann, H. et al.; Stiewe, T.; Pullamsetti, S. S.; Savai, R.: miR-147b mediated suppression of DUSP8 promotes lung cancer progression. ONCOGENE (2024)

Zheng, X.; Sarode, P.; Weigert , A.; Turkowski, K.; Chelladurai, P.; Guenther, S.; Kuenne, C.; Winter , H.; Stenzinger, A.; Reu, S. et al.; Grimminger, F.; Stiewe, T.; Seeger, W.; Pullamsetti, S. S.; Savai, R.: The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization. CANCER RESEARCH 83 (14), S. 2345 - 2357 (2023)

Weigert, A.; Zheng, X.; Nenzel, A.; Turkowski, K.; Guenther, S.; Strack, E.; Sirait-Fischer, E.; Elwakeel, E.; Kur, I. M.; Nikam, V. S. et al.; Valasarajan, C.; Winter, H.; Wissgott, A.; Voswinkel, R.; Grimminger, F.; Brune, B.; Seeger, W.; Pullamsetti, S. S.; Savai, R.: Fibrocytes boost tumor-supportive phenotypic switches in the lung cancer niche via the endothelin system. NATURE COMMUNICATIONS 13 (1), 6078 (2022)

Brunn, D.; Turkowski, K.; Gunther, S.; Weigert, A.; Muley, T.; Kriegsmann, M.; Winter, H.; Dammann, R. H.; Stathopoulos, G. T.; Thomas, M. et al.; Guenther, A.; Grimminger, F.; Pullamsetti, S. S.; Seeger, W.; Savai, R.: Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of Versican. CANCERS 13 (2), 208 (2021)

Turkowski, K.; Herzberg, F.; Guenther, S.; Brunn, D.; Weigert, A.; Meister, M.; Muley, T.; Kriegsmann, M.; Schneider, M. A.; Winter, H. et al.; Thomas, M.; Grimminger, F.; Seeger, W.; Pullamsetti, S. S.; Savai, R.: Fibroblast Growth Factor-14 Acts as Tumor Suppressor in Lung Adenocarcinomas. CELLS 9 (8), 1755 (2020)

Baig, M. S.; Roy, A.; Saqib, U.; Rajpoot, S.; Srivastava, M.; Naim, A.; Liu, D.; Saluja, R.; Faisal, S. M.; Pan, Q. et al.; Turkowski, K.; Darwhekar, G. N.; Savai, R.: Repurposing Thioridazine (TDZ) as an anti-inflammatory agent. SCIENTIFIC REPORTS 8, 12471 (2018)

Turkowski, K.; Brandenburg, S.; Mueller, A.; Kremenetskaia, I.; Bungert, A. D.; Blank, A.; Felsenstein, M.; Vajkoczy, P.: VEGF as a modulator of the innate immune response in glioblastoma. GLIA 66 (1), S. 161 - 174 (2018)

Turkowski, K.; Haselbauer, T.; Kaduthanam, S.; Sueltmann, H.; Grimminger, F.; Seeger, W.; Savai, R.: Macrophage and Cancer Cell Crosstalk Regulated MicroRNA 147b Plays a Crucial Role in Lung Cancer Progression. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE 197 (2018)

Zheng, X.; Turkowski, K.; Mora, J.; Brne, B.; Seeger, W.; Weigert, A.; Savai, R.: Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy. ONCOTARGET 8 (29), S. 48436 - 48452 (2017)